Non-melanocytic mimics of melanoma, part II: Intradermal mimics

Journal of Clinical Pathology

Volumn 62, Issue 4, 2009, Pages 290-307

  Tong, L C B ^a   Kamil, Z S ^a   Habeeb Al, A ^a   Ghazarian, D ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD99 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; GLYCOPROTEIN P; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PROTEIN BCL 2; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR; VIMENTIN;

ANGIOSARCOMA; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL FEATURE; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; EPITHELIOID SARCOMA; FIBROXANTHOMA; FOLLICULAR DENDRITIC CELL SARCOMA; GRANULAR CELL TUMOR; HISTIOCYTOSIS X; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE XANTHOGRANULOMA; KAPOSI SARCOMA; KIDNEY CARCINOMA; LEIOMYOSARCOMA; LUNG CARCINOMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MELANOMA; MERKEL CELL TUMOR; NEUROTHEKEOMA; PERIVASCULAR EPITHELIOID CELL NEOPLASM; PLASMA CELL GRANULOMA; PLEXIFORM FIBROHISTIOCYTIC TUMOR; PRIMITIVE NON NEURAL GRANULAR CELL TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RETICULOHISTIOCYTOSIS; REVIEW; RHABDOMYOSARCOMA; SCAR; SKIN METASTASIS; SKIN TUMOR; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SYNOVIAL SARCOMA; THYROID CARCINOMA; XANTHOGRANULOMA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MELANOMA; SKIN DISEASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 65849201873     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.062927     Document Type: Review

References (84)

1. Monteagudo C, Calduch L, Navarro S, et al. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Am J Clin Pathol 2002;117:126-131
2. Plaza JA, Suster D, Perez-Montiel D. Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique. Appl Immunohistochem Mol Morphol 2007;15:421-425 (Pubitemid 350307848)
3. Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 2002;29:562-568 (Pubitemid 35193300)
4. Kanitakis J, Narvaez D, Claudy A. Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res 2002;12:241-244 (Pubitemid 34666814)
5. Went PT, Dirnhofer S, Bundi M, et al. Prevalence of KIT expression in human tumors. J Clin Oncol 2004;22:4514-4522
6. Pernick NL, DaSilva M, Gangi MD, et al. "Histiocytic markers" in melanoma. Mod Pathol 1999;12:1072-1077
7. Kim YC, Lee MG, Choe SW, et al. Acral lentiginous melanoma: an immunohistochemical study of 20 cases. Int J Dermatol 2003;42:123-129
8. Ben-Izhak O, Stark P, Levy R, et al. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases. Am J Dermatopathol 1994;16:241-246
9. Wilkerson AE, Glasgow MA, Hiatt KM. Immunoreactivity of CD99 in invasive malignant melanoma. J Cutan Pathol 2006;33:663-666 (Pubitemid 44536345)
10. Leader M, Collins M, Patel J, et al. Vimentin: an evaluation of its role as a tumour marker. Histopathology 1987;11:63-72.
11. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab Invest 1989;61:623-628
12. Margo CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol 2006;19(Suppl 2):S41-70. (Pubitemid 43172309)
13. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996;20:1489-1500
14. Anstey A, Cerio R, Ramnarain N, et al. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14-22. (Pubitemid 9129975)
15. Kay PA, Pinheiro AD, Lohse CM, et al. Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases. Int J Surg Pathol 2004;12:17-24.
16. Nakagawa H, Imakado S, Nogita T, et al. Osteosarcomatous changes in malignant melanoma. Immunohistochemical and ultrastructural studies of a case. Am J Dermatopathol 1990;12:162-168
17. Sheibani K, Battifora H. Signet-ring cell melanoma. A rare morphologic variant of malignant melanoma. Am J Surg Pathol 1988;12:28-34.
18. Rütten A, Huschka U, Requena C, et al. Primary cutaneous signet-ring cell melanoma: a clinico-pathologic and immunohistochemical study of two cases. Am J Dermatopathol 2003;25:418-422
19. Breier F, Feldmann R, Fellenz C, et al. Primary invasive signet-ring cell melanoma. J Cutan Pathol 1999;26:533-536
20. Gavino AC, Gillies EM. Metastatic rhabdoid melanoma: report of a case with a comparative review of the literature. J Cutan Pathol 2008;35:337-342
21. Borek BT, McKee PH, Freeman JA, et al. Primary malignant melanoma with rhabdoid features: a histologic and immunocytochemical study of three cases. Am J Dermatopathol 1998;20:123-127
22. Aisner DL, Maker A, Rosenberg SA, et al. Loss of S100 antigenicity in metastatic melanoma. Hum Pathol 2005;36:1016-1019
23. Dauer EH, Lewis JE, Rohlinger AL, et al. Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 2008;138:347-352
24. Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002;24:309-312.
25. Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2001;38:135-140
26. El-Shabrawi-Caelen L, Kerl K, Cerroni L, et al. Cutaneous inflammatory pseudotumor - a spectrum of various diseases? J Cutan Pathol 2004;31:605-611
27. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumors: where are we now? J Clin Pathol 2008;61:428-437
28. Singh Gomez C, Calonje E, Fletcher CD. Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology 1994;24:123-129 (Pubitemid 24192273)
29. Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 1994;18:668-676
30. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopatholgic study of 174 cases with cutaneous and extracutaneous manisfestations. Am J Surg Pathol 2003;27:579-593 (Pubitemid 36514470)
31. Janssen D, Harms, D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry. Am J Surg Pathol 2005;29:21-28 (Pubitemid 40023949)
32. Hornick JL, Fletcher CD. Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol 2007;31:329-340 (Pubitemid 46673106)
33. Wang AR, May D, Bourne P, et al. PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol 1999;23:1401-1407
34. Campbell LK, Thomas JR, Lamps LW, et al. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol 2003;16:963-969 (Pubitemid 36629318)
35. Sachdev R, Sundram UN. Frequent positive staining with NKI/C3 in normal and neoplastic tissues limits its usefulness in the diagnosis of cellular neurothekeoma. Am J Clin Pathol 2006;126:554-563 (Pubitemid 44498505)
36. Fullen DR, Lowe L, Su LD. Antibody to S100A6 protein is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol 2003;30:118-122 (Pubitemid 36384856)
37. Alkhalidi H, Ghazarian D. Cellular neurothekeoma with a plexiform morphology: a case report with a discussion of the plexiform lesions of the skin. J Cutan Pathol 2007;34:264-269 (Pubitemid 46239316)
38. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 2006;30:521-528 (Pubitemid 43740155)
39. Ray S, Jukic DM. Cutaneous granular cell tumor with epidermal involvement: a potential mimic of melanocytic neoplasia. J Cutan Pathol 2007;34:188-194 (Pubitemid 46145560)
40. Gleason BC, Nascimento AF. HMB-45 and Melan-A are useful markers in the differential diagnosis between granular cell tumor and malignant melanoma. Am J Dermatopathol 2007;29:22-27 (Pubitemid 46220235)
41. Flope AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 2005;29:1558-1575 (Pubitemid 40486339)
42. Weinreb I, Howarth D, Latta E, et al. Perivascular epithelioid cell neoplasms (PEComas): four malignant cases extending the histopathological spectrum and a description of a unique finding. Virchows Arch 2007;450:463-470
43. LeBoit PE, Barr RJ, Burall S, et al. Primitive polypoid granular-cell tumor and other cutaneous granular-cell neoplasms of apparent nonneural origin. Am J Surg Pathol 1991;15:48-58.
44. Habeeb AA, Salama S. Primitive nonneural granular cell tumor (so-called atypical polypoid granular cell tumor). Report of 2 cases with immunohistochemical and ultrastructural correlation. Am J Dermatopathol 2008;30:156-159
45. Lazar AJ, Fletcher CD. Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases. Am J Surg Pathol 2005;29:927-934 (Pubitemid 40885016)
46. Chaudhry IH, Calonje E. Dermal non-neural granular cell tumour (so-called primitive polypoid granular cell tumour): a distinctive entity further delineated in a clinicopathological study of 11 cases. Histopathology 2005;47:179-185 (Pubitemid 41113121)
47. Calonje E. Non-melanocytic lesions mimicking melanocytic lesions. Pathology 2004;36:387-395 (Pubitemid 39273981)
48. Punia RS, Bagai M, Mohan H, et al. Langerhans cell histiocytosis of skin: a clinicopathologic analysis of five cases. Indian J Dermatol Venereol Leprol 2006;72:211-214
49. Meehan SA, Smoller BR. Cutaneous Langerhans cell histiocytosis of the genitalia in the elderly: a report of three cases. J Cutan Pathol 1998;25:370-374 (Pubitemid 28425464)
50. Mizumoto N, Takashima A. CD1a and langerin: acting as more than Langerhans cell markers. J Clin Invest 2004.
51. Seo IS, Goheen M, Min KW. Bednar tumor: report of a case with immunohistochemical and ultrastructural study. Ultrastruct Pathol 2003;27:205-210 (Pubitemid 36920530)
52. Diaz-Cascajo C, Weyers W, Borghi S. Pigmented atypical fibroxanthoma: a tumor that may be easily mistaken for malignant melanoma. Am J Dermatopathol 2003;25:1-5. (Pubitemid 36133263)
53. Hultgren TL, DiMaio DJ. Immunohistochemical staining of CD10 in a typical fibroxanthomas. J Cutan Pathol 2007;34:415-419 (Pubitemid 46633344)
54. Shimada S, Tsuzuki T, Kuroda, M, et al. Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int 2007;57:60-67
55. Allison KH, Patel RM, Goldblum JR, et al. Superficial malignant peripheral nerve sheath tumor: a rare and challenging diagnosis. Am J Clin Pathol 2005;124:685-692
56. Laskin WB, Weiss SW, Bratthauer GI. Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma). Am J Surg Pathol 1991;15:1136-1145
57. Kaddu S, Beham A, Cerroni L, et al. Cutaneous leiomyosarcoma. Am J Surg Pathol 1997;21:979-987
58. Choy C, Cooper A, Kossard S. Primary cutaneous diffuse leiomyosarcoma with desmoplasia. Australas J Dermatol 2006;47:291-295 (Pubitemid 44536229)
59. Bellezza G, Sidoni A, Cavaliere A, et al. Primary cutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 7 cases. Int J Surg Pathol 2004;12:39-44.
60. Brightman LA, Demierre MF, Byers HR, et al. Macrophage-rich epithelioid angiosarcoma mimicking malignant melanoma. J Cutan Pathol 2006;33:38-42.
61. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol 2006;13:141-221 (Pubitemid 44341662)
62. Lin O, Gerhard R, Coelho Siqueira SA, et al. Cytologic findings of epithelioid angiosarcoma of the thyroid. A case report. Acta Cytol 2002;46:767-771
63. Laskin WB, Miettinen M. Epithelioid sarcoma: new insights based on extended immunohistochemical analysis. Arch Pathol Lab Med 2003;127:1161-1168 (Pubitemid 37093265)
64. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol 1999;30:934-942
65. Dotto JE, Glusac EJ. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 2006;33:413-417 (Pubitemid 43865299)
66. Weiss SW, Goldblum JR. Benign tumors of peripheral nerves. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss;s soft tissue tumors. 5th edn. St Louis (MO): Mosby, 2008:886-887
67. LeBoit PE, Crutcher WA, Shapiro PE. Pagetoid intraepidermal spread in Merkel cell (primary neuroendocrine) carcinoma of the skin. Am J Surg Pathol 1992;16:584-592
68. Bickle K, Glass LF, Messina JL, et al. Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg 2004;23:46-53.
69. Smith KJ, Skelton III HG, Holland TT, et al. Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component. Am J Dermatopathol 1993;15:528-533
70. Youens KE, Waugh MS. Extranodal follicular dendritic cell sarcoma. Arch Pathol Lab Med 2008;132:1683-1687
71. Chan JK, Fletcher CD, Nayler SJ, et al. Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294-313.
72. Craddock KJ, Labonte S, Ghazarian D. Anaplastic Kaposi sarcoma resembling epithelioid angiosarcoma in an HIV-positive man. Eur J Dermatol 2008;18:358-359
73. Moosavi C, Jha P, Fanburg-Smith JC. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD. Ann Diagn Pathol 2007;11:313-319
74. Folpe AL, Schmidt RA, Chapman D, et al. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22:673-682
75. Flieder DB, Moran CA. Primary cutaneous synovial sarcoma: a case report. Am J Dermatopathol 1998;20:509-512 (Pubitemid 28463423)
76. Azoulay S, Adem C, Pelletier F, et al. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin. J Cutan Pathol 2005;32:561-566
77. Krathen RA. Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 2003;96:164-167 (Pubitemid 36268589)
78. D'Aniello C, Brandi C, Grimaldi L. Cutaneous metastasis from small cell lung carcinoma. Scand J Plast Reconstr Surg Hand Surg 2001;35:103-105 (Pubitemid 32222660)
79. Molina Garrido MJ, Guillen Ponce C, Soto Martinez JL, et al. Cutaneous metastases of lung cancer. Clin Transl Oncol 2006;8:330-333
80. Mueller TJ, Wu H, Greenberg RE, et al. Cutaneous metastases from genitourinary malignancies. Urology 2004;63:1021-1026
81. Dahl PR, Brodland DG, Goellner JR, et al. Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy. J Am Acad Dermatol 1997;36:531-537
82. Koller EA, Tourtelot JB, Pak HS, et al. Papillary and follicular thyroid carcinoma metastatic to the skin: a case report and review of the literature. Thyroid 1998;8:1045-1050
83. Alwaheeb S, Ghazarian D, Boerner SL, et al. Cutaneous manifestations of thyroid cancer: a report of four cases and review of the literature. J Clin Pathol 2004;57:435-438
84. Paz-Ares L, Olivia E, Carey RW, et al. Skin lesions in malignancy. Case 2. Skin metastases from prostate adenocarcinoma. J Clin Oncol 2001;19:2099-2100